NCT06680531View on ClinicalTrials.gov

A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

September 18, 2024

Study Completion Date

January 31, 2025

Conditions
InsomniaCentral Nervous System
Interventions
DRUG

YZJ-1139 tablets

YZJ-1139 tablets are administered orally single dose

DRUG

Escitalopram oxalate tablets

•oral tablet, QD

DRUG

YZJ-1139 simulated tablets

oral tablet, QD

Trial Locations (1)

Unknown

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

INDUSTRY